Evidence map›Paper›PMID 26232233›Full record

ReviewAmerican journal of physiology. Heart and circulatory physiology2015

Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Luciano F Drager, Vsevolod Y Polotsky, Christopher P O'Donnell, Sergio L Cravo, Geraldo Lorenzi-Filho, Benedito H Machado

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 116 citations in OpenAlex.

  1. Trial
  2. Awake Multimodal Phenotyping for Prediction of Oral Appliance Treatment Outcome.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2018
    Trial
  3. Trial
  4. Sleep, Neural Circulatory Control, and Cardiovascular Disease: A Mechanistic Review.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. International Consensus Statement on Obstructive Sleep Apnea.International forum of allergy & rhinology · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Luciano F DragerHypertension Unit, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil; Hypertension Unit, Renal Division, University of São Paulo Medical School, São Paulo, Brazil; luciano.drager@incor.usp.br.
Vsevolod Y PolotskyDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Christopher P O'DonnellDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania;
Sergio L CravoDepartment of Physiology, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil;
Geraldo Lorenzi-FilhoSleep Laboratory, Pulmonary Division, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil; and.
Benedito H MachadoDepartment of Physiology, School of Medicine of Ribeirao Preto, University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRJohns Hopkins Medicine · USUniversidade Federal de São Paulo · BRUniversity of Pittsburgh · US

Funding

JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI AHIMA, REXFORD S. · 2013 to 2017
$9.7M
Sleep Apnea and Dysregulation of Lipid MetabolismR01HL080105 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POLOTSKY, VSEVOLOD Y · 2005 to 2014
$3.4M
NIDDK NIH HHS P30 DK079637
6 · The paper itself

Abstract

Obstructive sleep apnea (OSA) is known to be independently associated with several cardiovascular diseases including hypertension, myocardial infarction, and stroke. To determine how OSA can increase cardiovascular risk, animal models have been developed to explore the underlying mechanisms and the cellular and end-organ targets of the predominant pathophysiological disturbance in OSA-intermittent hypoxia. Despite several limitations in translating data from animal models to the clinical arena, significant progress has been made in our understanding of how OSA confers increased cardiovascular risk. It is clear now that the hypoxic stress associated with OSA can elicit a broad spectrum of pathological systemic events including sympathetic activation, systemic inflammation, impaired glucose and lipid metabolism, and endothelial dysfunction, among others. This review provides an update of the basic, clinical, and translational advances in our understanding of the metabolic dysfunction and cardiovascular consequences of OSA and highlights the most recent findings and perspectives in the field.

Indexed as

Lipid MetabolismAnimalsAutonomic Nervous System DiseasesBlood GlucoseCardiovascular DiseasesContinuous Positive Airway PressureDiabetes Mellitus, Type 2Disease Models, AnimalGlucoseHumansHypertensionHypoxiaInflammationInsulin ResistanceNon-alcoholic Fatty Liver DiseaseSleep Apnea, ObstructiveBlood GlucoseGlucosecardiovascular diseaseintermittent hypoxiasleep apneatranslational medicine

Identifiers

PMID26232233
PMCPMC4816265
OpenAlexW1922857604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.